
4.17BUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04530Y1064
CUSIP
04530Y106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
11.11
Dividend Share
2.32
Dividend Yield
1.46%
Earnings Share
-0.12
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
34,870,001,664
Gross Profit TTM
14,798,999,552
EBITDA
6,870,000,128
Profit Margin
7.59%
Return On Assets TTM
2.69%
Return On Equity TTM
-1.08%
Revenue Per Share TTM
78.518
Qtly Revenue Growth YOY
1.70%
Diluted Eps TTM
-0.12
Qtly Earnings Growth YOY
-38.40%
Trailing PE
0.00
Forward PE
5
Price Sales TTM
0.1196
Price Book MRQ
0.862
Enterprise Value Revenue
1
Enterprise Value EBITDA
20
13.00
6.11%8.91
1.48%20.80
0.31%98.42
0.00%41.10
-1.82%33.21
-1.48%45.90
-1.46%167.45
-1.17%40.91
-0.44%228.00
-0.44%